Brief: I'rom Group Co Ltd Says To Buy Back Up To 1.12 Percent Of Own Shares Worth 200 Million Yen Through March 29
9-MTH group results
6-MTH group results
Brief: I'rom Group unit signs license agreement with Censo Biotechnologies
Brief: I'rom Group unit concludes iPS cell generation technology licensing agreement with UK-based Elpis Biomed
Brief: I'rom Group signs partnership agreement with China co Beroni Group
Q1 group results
Brief: I'rom Group signs cooperation agreement with DENDRIX on advanced medical business
Brief: I'rom Group unit concludes iPS cell generation technology licensing agreement with Evotec International GmbH
2017/18 group results
2017/18 parent results
2017/18 group forecast
9-MTH group results
Brief: I'rom Group unit ID Pharma signs iPS cell generation technology licensing agreement with U.S.-based QurAlis
Brief: I'rom Group to set up unit in Hong Kong to management and support co's business in China
Brief: I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences
6-MTH group results
Brief: I'rom Group says business and capital alliance with OKWAVE unit
Brief: I'rom Group fully acquires CMAX Clinical Research Pty for A$6.2 mln